|
|
||||||||
1 Lipoprotein Research Group and Department of Biochemistry, Dalhousie University, Halifax, Nova Scotia B3H 4H7; and 2 Health Sciences Laboratory Animal Services and 3 Lipid and Lipoprotein Research Group and Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada T6G 2S2
In
-naphthylisothiocyanate-treated mice,
plasma phospholipid (PL) levels were elevated 10- and 13-fold at 48 and
168 h, respectively, whereas free cholesterol (FC) levels increased
between 48 h (17-fold) and 168 h (39-fold). Nearly all of these lipids
were localized to lipoprotein X-like particles in the low-density
lipoprotein density range. The PL fatty acyl composition was indicative
of biliary origin. Liver cholesterol and PL content were near normal at
all time points. Hepatic hydroxymethylglutaryl CoA reductase activity
was increased sixfold at 48 h, and cholesterol 7
-hydroxylase activity was decreased by ~70% between 24 and 72 h. These findings suggest a metabolic basis for the appearance of abnormal plasma lipoproteins during cholestasis. Initially, PL and bile acids appear in
plasma where they serve to promote the efflux of cholesterol from
hepatic cell membranes. Hepatic cholesterol synthesis is then likely
stimulated in the response to the depletion of hepatic cell membranes
of cholesterol. We speculate that the enhanced synthesis of cholesterol
and impaired conversion to bile acids, particularly during the early
phase of drug response, contribute to the accumulation of FC in the plasma.
cholesterol 7
-hydroxylase; hydroxymethylglutaryl coenzyme A
reductase; lipoproteins; bile acids;
-naphthylisothiocyanate
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |